RecruitingAccepts healthy volunteersPhase 1
Study of MAR002 in Healthy Men
Marea Therapeutics · NCT07195175
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–40 · Men only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 45
- US sites recruiting
- 1
- Study start
- August 11, 2025
- Record last updated
- January 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Being studied: MAR002; Placebo
Conditions: Acromegaly
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willingness to provide written informed consent
- Age 18 to 40
- Weight 55 to 95 kg
- Body mass index (BMI) 18 to 30 kg/m2
- Healthy men
Exclusion Criteria
- History of hypersensitivity to monoclonal antibodies or study drug
- Participation in any other investigational drug study
- History of cancer
- Recent acute illness
- Positive test for HIV, hepatitis B/C
- History of substance abuse or nicotine use
- Recent blood donation
- History of pituitary disorder
- Any condition that prevents the participant from complying with study procedures
Recruiting US locations
Marea Site
Tempe, AZ 85283
Study contacts (from the official record)
- Andrew Lane · 415-766-3610 · mar-201-info@mareatx.com
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55